Amplia Therapeutics Ltd
ASX:ATX
Amplia Therapeutics Ltd
ASX:ATX
Price:
0.12
AUD
-4%
Market Closed
Market Cap:
AU$61.6m
Wall Street
Price Targets
ATX Price Targets Summary
Amplia Therapeutics Ltd
Amplia Therapeutics Ltd
Wall Street analysts forecast ATX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
ATX
is 0.43 AUD
with a low forecast of 0.42 AUD and a high forecast of 0.44 AUD.
Lowest
Price Target
0.42
AUD
254% Upside
Average
Price Target
0.43
AUD
257% Upside
Highest
Price Target
0.44
AUD
268% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ATX's stock price target?
Price Target
0.43
AUD
0.43
AUD
According to Wall Street analysts, the average 1-year price target for
ATX
is 0.43 AUD
with a low forecast of 0.42 AUD and a high forecast of 0.44 AUD.
What is Amplia Therapeutics Ltd's Revenue forecast?
Projected CAGR
39%
39%
For the last 12 years the
compound annual growth rate for
Amplia Therapeutics Ltd's revenue is
25%.
The projected
CAGR
for the next 3 years is
39%.
